NATURE’S SUNSHINE PRODUCTS, INC. Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost of $1.25 million as of 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense › Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost · last filed 2026-03-10
- 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $1.25M.
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $1.26M.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $1.06M.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $797.00K.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost |
|---|---|
| 2025-12-31 | $1.25M 10-K · filed 2026-03-10 |
| 2024-12-31 | $1.26M 10-K · filed 2026-03-10 |
| 2023-12-31 | $1.06M 10-K · filed 2025-03-11 |
| 2022-12-31 | $797.00K 10-K · filed 2024-03-12 |
| 2021-12-31 | $877.00K 10-K · filed 2023-03-16 |
| 2020-12-31 | $1.33M 10-K · filed 2022-03-08 |
| 2019-12-31 | $1.13M 10-K · filed 2021-03-10 |
| 2018-12-31 | $2.36M 10-K · filed 2020-03-11 |
| 2017-12-31 | $3.09M 10-K · filed 2019-03-08 |
| 2016-12-31 | $5.03M 10-K · filed 2018-03-16 |
| 2015-12-31 | $4.66M 10-K · filed 2017-03-14 |
| 2014-12-31 | $4.29M 10-K · filed 2016-03-14 |
| 2013-12-31 | $2.99M 10-K · filed 2015-03-13 |
| 2012-12-31 | $2.59M 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |